Ian is the editor and a director of Proactive Investors. He oversees all editorial output and is also heavily involved with business development. He moved to Proactive from the Daily Mail, where he was City News Editor and Investment Editor and brings with him a wealth of experience in business and finance. At the Mail he directed the coverage of some of the biggest stories ever to emerge from the City as the credit crunch and banking crisis felled some of the nation's best known financial institutions. In his 20 years as a business reporter and editor Ian has worked for Dow Jones, writing stories for the international news wire and the Wall Street Journal. He also led the London company coverage for AFX News, now part of Reuters.
Operationally and financially, the company is on track
The antibiotic specialist's shares nudged higher on the news
The UK life sciences group has partnered with Seed Health in the States
Avacta has teamed up with FIT Biotech to find a way of delivering DNA treatments more effectively
The patent protects a new class of cancer vaccines rolling off the Moditope platform
Jonathan Milner's exit ends a decade-long association with Horizon and he wished the team there well, adding he felt "enormously privileged to have been a part of this exciting journey"
Its drug targeting people with chronic obstructive pulmonary disease failed to make a statistically meaningful difference
Stephanie Noviello, who will report into chief medical officer David Huang, joins from Bristol-Myers Squibb
Two companies, three wells
Drilling down into the world of E&P as we keep tabs of on the gushers and dusters
A look at some early analyst views in the City
The bookmakers have been put under the microscope, while Shell has been downgraded.